Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Veterans Crisis Line Badge
Go to the ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

216 records found for:
Title = Heart Disease
Year =

  1. Mahtta D, Virani SS. Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit? Journal of medical economics. 2020 Apr 29; 1-3.
  2. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3; 141(9):e139-e596.
  3. Shah NR, Ahmed ST, Winchester DE, Ramsey DJ, Akeroyd JM, Wu WC, Waldo SW, Schofield RS, Ballantyne CM, Petersen LA, Virani SS. Facility-Level Variation in Stress Test Utilization in Veterans With Ischemic Heart Disease. JACC. Cardiovascular imaging. 2019 Jul 1; 12(7 Pt 1):1292-1293.
  4. Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J, CARDIoGRAMPlusC4D Consortium , Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events. Circulation. Genomic and precision medicine. 2019 Apr 1; 12(4):e002471.
  5. Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW. Subsequent Event Risk in Individuals With Established Coronary Heart Disease. Circulation. Genomic and precision medicine. 2019 Apr 1; 12(4):e002470.
  6. Bowling CB, Davis BR, Luciano A, Simpson LM, Sloane R, Pieper CF, Einhorn PT, Oparil S, Muntner P. Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT. Journal of clinical hypertension (Greenwich, Conn.). 2019 Apr 1; 21(4):451-459.
  7. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5; 139(10):e56-e528.
  8. Puri K, Singh H, Denfield SW, Cabrera AG, Dreyer WJ, Tunuguntla HP, Price JF. Missed Diagnosis of New-Onset Systolic Heart Failure at First Presentation in Children with No Known Heart Disease. The Journal of Pediatrics. 2019 May 1; 208:258-264.e3.
  9. Dayoub EJ, Nathan AS, Khatana SAM, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Groeneveld PW, Giri J. Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016. Circulation. Cardiovascular interventions. 2019 Jan 1; 12(1):e007434.
  10. O'Hanlon CE. What kills us and what moves us: A comparative discourse analysis of heart disease and breast cancer. Digital health. 2019 Jan 1; 5:https://doi.org/10.1177/2055207619844865.
  11. Krishnamurthi N, Schopfer DW, Ahi T, Bettencourt M, Piros K, Ringer R, Shen H, Kehler JP, Whooley MA. Predictors of Patient Participation and Completion of Home-Based Cardiac Rehabilitation in the Veterans Health Administration for Patients With Coronary Heart Disease. The American journal of cardiology. 2019 Jan 1; 123(1):19-24.
  12. Fudim M, Fathallah M, Shaw LK, Liu PR, James O, Samad Z, Piccini JP, Hess PL, Borges-Neto S. The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease. JACC. Cardiovascular imaging. 2019 Jul 1; 12(7 Pt 1):1215-1226.
  13. Groeneveld PW, Medvedeva EL, Walker L, Segal AG, Richardson DM, Epstein AJ. Outcomes of Care for Ischemic Heart Disease and Chronic Heart Failure in the Veterans Health Administration. JAMA cardiology. 2018 Jul 1; 3(7):563-571.
  14. Chokshi NP, Adusumalli S, Small DS, Morris A, Feingold J, Ha YP, Lynch MD, Rareshide CAL, Hilbert V, Patel MS. Loss-Framed Financial Incentives and Personalized Goal-Setting to Increase Physical Activity Among Ischemic Heart Disease Patients Using Wearable Devices: The ACTIVE REWARD Randomized Trial. Journal of the American Heart Association. 2018 Jun 13; 7(12).
  15. Briasoulis A, Inampudi C, Akintoye E, Alvarez P, Panaich S, Vaughan-Sarrazin M. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease. Journal of the American Heart Association. 2018 Apr 5; 7(8).
  16. Patel J, Al Rifai M, Scheuner MT, Shea S, Blumenthal RS, Nasir K, Blaha MJ, McEvoy JW. Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis. Mayo Clinic proceedings. 2018 Sep 1; 93(9):1213-1223.
  17. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 Mar 20; 137(12):e67-e492.
  18. Ahmed ST, Rehman H, Akeroyd JM, Alam M, Shah T, Kalra A, Virani SS. Premature Coronary Heart Disease in South Asians: Burden and Determinants. Current Atherosclerosis Reports. 2018 Jan 27; 20(1):6.
  19. Levy AE, Huang C, Huang A, Michael Ho P. Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System. Current Atherosclerosis Reports. 2018 Jan 24; 20(1):5.
  20. Salmoirago-Blotcher E, Wayne PM, Dunsiger S, Krol J, Breault C, Bock BC, Wu WC, Yeh GY. Tai Chi Is a Promising Exercise Option for Patients With Coronary Heart Disease Declining Cardiac Rehabilitation. Journal of the American Heart Association. 2017 Oct 11; 6(10).
  21. Zullig LL, Ramos K, Bosworth HB. Improving Medication Adherence in Coronary Heart Disease. Current Cardiology Reports. 2017 Sep 22; 19(11):113.
  22. McSweeney JC, Cleves MA, Fischer EP, Pettey CM, Beasley B. Using the McSweeney Acute and Prodromal Myocardial Infarction Symptom Survey to Predict the Occurrence of Short-Term Coronary Heart Disease Events in Women. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2017 Nov 1; 27(6):660-665.
  23. Xie JX, Winchester DE, Phillips LM, Hachamovitch R, Berman DS, Blankstein R, Di Carli MF, Miller TD, Al-Mallah MH, Shaw LJ. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?. Journal of Nuclear Cardiology : Official Publication of The American Society of Nuclear Cardiology. 2017 Oct 1; 24(5):1610-1618.
  24. Patterson OV, Freiberg MS, Skanderson M, J Fodeh S, Brandt CA, DuVall SL. Unlocking echocardiogram measurements for heart disease research through natural language processing. BMC cardiovascular disorders. 2017 Jun 12; 17(1):151.
  25. Kalra A, Bhatt DL, Rajagopalan S, Suri K, Mishra S, Iqbal R, Virani SS. Overview of Coronary Heart Disease Risk Initiatives in South Asia. Current Atherosclerosis Reports. 2017 Jun 1; 19(6):25.
  26. Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS, GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. The lancet. Diabetes & endocrinology. 2017 Jul 1; 5(7):534-543.
  27. Ziaeian B, Fonarow GC. Statins and the Prevention of Heart Disease. JAMA cardiology. 2017 Apr 1; 2(4):464.
  28. Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, Sarnak MJ, Siscovick DS, Zelnick L, Psaty BM, Kestenbaum B, Correa A, Afkarian M, Young B, de Boer IH. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies. JAMA cardiology. 2017 Mar 1; 2(3):314-318.
  29. Effoe VS, Wagenknecht LE, Echouffo Tcheugui JB, Chen H, Joseph JJ, Kalyani RR, Bell RA, Wu WH, Casanova R, Bertoni AG. Sex Differences in the Association Between Insulin Resistance and Incident Coronary Heart Disease and Stroke Among Blacks Without Diabetes Mellitus: The Jackson Heart Study. Journal of the American Heart Association. 2017 Feb 2; 6(2).
  30. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7; 135(10):e146-e603.
  31. Bossi KE. HSR&D e-Pub Briefs-2: Summaries of select journal articles published by HSR&D investigators on PACT, Surgery, Heart Disease, Suicide, and QUERI. 2017 Jan 19; 9(2).
  32. Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. The American journal of cardiology. 2016 Oct 15; 118(8):1144-1149.
  33. Gillette M, Morneau K, Hoang V, Virani S, Jneid H. Antiplatelet Management for Coronary Heart Disease: Advances and Challenges. Current Atherosclerosis Reports. 2016 Jun 1; 18(6):35.
  34. Kaiser DW, Harrington RA, Turakhia MP. Wearable Fitness Trackers and Heart Disease. JAMA cardiology. 2016 May 1; 1(2):239.
  35. Schopfer DW, Priano S, Allsup K, Helfrich CD, Ho PM, Rumsfeld JS, Forman DE, Whooley MA. Factors Associated With Utilization of Cardiac Rehabilitation Among Patients With Ischemic Heart Disease in the Veterans Health Administration: A QUALITATIVE STUDY. Journal of cardiopulmonary rehabilitation and prevention. 2016 May 1; 36(3):167-73.
  36. Salami A, Elizondo JV, Ogunmoroti O, Spatz ES, Rana JS, Virani S, Blankstein R, Blaha MJ, Younus A, Arrieta A, Veledar E, Nasir K. Modifiable Risk Factors as Drivers of Pharmaceutical Expenditures Among US Adults with Atherosclerotic Heart Disease: 2012 Medical Expenditure Panel Survey. Poster session presented at: American Heart Association Epidemiology - Lifestyle and Cardiometabolic Health Annual Scientific Sessions; 2016 Mar 1; Phoenix, AZ.
  37. Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford MM, Patkar NM, Mikuls TR, Singh JA, Curtis JR. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Annals of The Rheumatic Diseases. 2016 Feb 1; 75(2):341-7.
  38. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):447-54.
  39. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26; 133(4):e38-60.
  40. Keach JW, Yeh RW, Maddox TM. Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease. Current Atherosclerosis Reports. 2016 Jan 1; 18(1):5.
  41. So-Armah K, Tate J, Lim JK, Lo Re V, Marconi V, Samet J, Gibert C, Leaf D, Butt A, Goetz MB, Rimland D, Rodriguez-Barradas M, Budoff M, Chang CC, Justice AC, Freiberg MS. Liver injury is associated with total cardiovascular disease, heart failure, stroke, coronary heart disease and acute myocardial infarction including among those without viral hepatitis (B or C), HIV, alcohol abuse and obesity. Paper presented at: American Heart Association Annual Scientific Sessions; 2015 Nov 16; Orlando, FL.
  42. Virani S. Chronic and Acute Ischemic Heart Disease II. Presented at: American Heart Association Annual Scientific Forum; 2015 Nov 11; Orlando, FL.
  43. Hira RS, Pokharel Y, Cowart J, Akeroyd JM, Ramsey J, Nambi V, Jneid H, Deswal A, Denktas A, Ballantyne CM, Petersen LA, Virani S. Compliance With Risk Factor Optimization and Medical Therapy in Patients With Peripheral Vascular Disease (Peripheral Artery and Ischemic Cerebrovascular Disease) Compared to Ischemic Heart Disease. Best of AHA Specialty Conferences: QCOR 2015. Presented at: American Heart Association Annual Scientific Sessions; 2015 Nov 7; Orlando, FL.
  44. So-Armah K, Tate J, Lim J, Lo Re V, Marconi V, Samet J, Gibert C, Leaf D, Butt A, Goetz MB, Rimland D, Rodriguez-Barradas M, Budoff M, Chang C, Justice A, Freiberg M. Liver Injury is Associated With Total Cardiovascular Disease, Heart Failure, Stroke, Coronary Heart Disease and Acute Myocardial Infarction Including Among Those Without Viral Hepatitis (B Or C), HIV, Alcohol Abuse and Obesity. Paper presented at: American Heart Association Scientific Sessions Late-Breaking Clinical Trial Report; 2015 Nov 7; Orlando, FL.
  45. Heidenreich PA. Interventions Using the Electronic Medical Record to Improve Care of Patients with Heart Disease. Presented at: International Academy of Cardiology Annual World Congress on Heart Disease; 2015 Jul 27; Vancouver, Canada.
  46. Hira RS, Pokharel Y, Cowart J, Akeroyd J, Ramsey D, Jneid H, Deswal A, Denktas A, Ballantyne CM, Petersen LA, Virani SS. Compliance with risk factor optimization and medical therapy in patients with peripheral vascular disease (peripheral artery and ischemic cerebrovascular disease) compared to ischemic heart disease. Paper presented at: American Heart Association Quality of Care and Outcomes Research Council Annual Scientific Session; 2015 Apr 29; Baltimore, MD.
  47. Damluji AA, Cohen ER, Rich MW, Forman DE. Insulin provision therapy and mortality in elderly patients with diabetes mellitus and stable ischemic heart disease: insights from BARI-2D trial. Presented at: American College of Cardiology Annual Scientific Session; 2015 Mar 17; San Diego, CA.
  48. Trivedi R, Gerrity M, Rumsfeld JS, Spertus JA, Sun H, McDonell M, Doak M, Lucas L, Fihn SD. Angina symptom burden associated with depression status among veterans with ischemic heart disease. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2015 Feb 1; 49(1):58-65.
  49. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27; 131(4):e29-322.
  50. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014 Nov 4; 130(19):1749-67.
  51. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2014 Nov 4; 64(18):1929-49.
  52. McSweeney J, Cleves MA, Fischer EP, Moser DK, Wei J, Pettey C, Rojo MO, Armbya N. Predicting coronary heart disease events in women: a longitudinal cohort study. The Journal of cardiovascular nursing. 2014 Nov 1; 29(6):482-92.
  53. Sico JJ, Myers L, Williams LS, Bravata DM. Coronary Heart Disease Screening: Are Ischemic Stroke Patients Receiving Guideline Concordant Care? Poster session presented at: American Neurological Association Annual Meeting; 2014 Oct 12; Baltimore, MD.
  54. Schopfer DW, Takemoto S, Allsup K, Helfrich CD, Ho PM, Forman DE, Whooley MA. Cardiac rehabilitation use among veterans with ischemic heart disease. JAMA internal medicine. 2014 Oct 1; 174(10):1687-9.
  55. Virani S, Woodard LD, Akeroyd JM, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA. Frequency and Correlates of Repeat Lipid Testing in Patients with Coronary Heart Disease. Poster session presented at: Baylor College of Medicine Quality and Safety Annual Conference; 2014 May 15; Houston, TX.
  56. Wong JM, Welles CC, Azarbal F, Whooley MA, Schiller NB, Turakhia MP. Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study). The American journal of cardiology. 2014 May 15; 113(10):1679-84.
  57. Crum-Cianflone NF, Bagnell ME, Schaller E, Boyko EJ, Smith B, Maynard C, Ulmer CS, Vernalis M, Smith TC. Impact of combat deployment and posttraumatic stress disorder on newly reported coronary heart disease among US active duty and reserve forces. Circulation. 2014 May 6; 129(18):1813-20.
  58. Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, Couper D, Virani SS, Kathiresan S, Boerwinkle E, Ballantyne CM. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2014 May 1; 34(5):1069-77.
  59. Azarbal F, Welles CC, Wong JM, Whooley MA, Schiller NB, Turakhia MP. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study). The American journal of cardiology. 2014 Apr 1; 113(7):1166-72.
  60. Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Rosenbaum L, Shaw LJ, Stainback RF, Allen JM, American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2014 Feb 4; 63(4):380-406.
  61. Multimodality Writing Group for Stable Ischemic Heart Disease, Wolk MJ, Bailey SR, Douglas PS, Kramer CM, Min JK, Patel MR, Rosenbaum L, Shaw LJ, Allen JM, Technical Panel, Brindis RG, Cerqueira MD, Chen J, Dean LS, Fazel R, Hundley WG, Itchhaporia D, Kligfield P, Lockwood R, Marine JE, McCully RB, Messer JV, O'Gara PT, Shemin RJ, Wann LS, Wong JB, Appropriate Use Criteria Task Force, Brown AS, Doherty JU, Hendel RC, Lindsay BD, Stainback RF. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. Journal of cardiac failure. 2014 Feb 1; 20(2):65-90.
  62. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
  63. Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circulation. Cardiovascular quality and outcomes. 2014 Jan 1; 7(1):78-85.
  64. Kansagara D, Dyer E, Englander H, Fu R, Freeman M, Kagen D. Treatment of anemia in patients with heart disease: a systematic review. Annals of internal medicine. 2013 Dec 3; 159(11):746-57.
  65. Sico JJ, Bravata DM. Coronary Heart Disease Screening: Are Ischemic Stroke Patients Receiving Guideline Concordant Care? Poster session presented at: American Heart Association Annual Scientific Sessions; 2013 Nov 18; Dallas, TX.
  66. Ogunwale A, Morrison AC, Dodge R, Virani S, Taylor A, Gottesman R, Yang E, Wei P, Boerwinkle E, Heiss G, Ballantyne CM, Nambi C. Multiple Single Day Blood Pressure Measurements and Their Impact on Coronary Heart Disease, Stroke, and Heart Failure Risk Prediction: The Atherosclerosis Risk In Communities (ARIC) Study. Poster session presented at: American Heart Association Annual Scientific Forum; 2013 Nov 17; Dallas, TX.
  67. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. The American journal of cardiology. 2013 Nov 1; 112(9):1287-92.
  68. Williams W, Kunik ME, Springer J, Graham DP. Can personality traits predict the future development of heart disease in hospitalized psychiatric veterans? Journal of psychiatric practice. 2013 Nov 1; 19(6):477-89.
  69. Virani SS, Woodard LD, Wang D, Chitwood SS, Landrum CR, Urech TH, Pietz K, Chen GJ, Hertz B, Murawsky J, Ballantyne CM, Petersen LA. Correlates of repeat lipid testing in patients with coronary heart disease. JAMA internal medicine. 2013 Aug 12; 173(15):1439-44.
  70. Won CH, Chun HJ, Chandra SM, Sarinas PS, Chitkara RK, Heidenreich PA. Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep & Breathing = Schlaf & Atmung. 2013 Mar 1; 17(1):85-91.
  71. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1; 127(1):143-52.
  72. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1; 127(1):e6-e245.
  73. Qaseem A, Fihn SD, Dallas P, Williams S, Owens DK, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Annals of internal medicine. 2012 Nov 20; 157(10):735-43.
  74. Qaseem A, Fihn SD, Williams S, Dallas P, Owens DK, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Annals of internal medicine. 2012 Nov 20; 157(10):729-34.
  75. Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK. Association between ß-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Thorax. 2012 Nov 1; 67(11):977-84.
  76. Laporta R, Anandam A, El-Solh AA. Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system. Clinical research in cardiology : official journal of the German Cardiac Society. 2012 Sep 1; 101(9):737-44.
  77. Rice TB, Foster GD, Sanders MH, Unruh M, Reboussin D, Kuna ST, Millman R, Zammit G, Wing RR, Wadden TA, Kelley D, Pi-Sunyer X, Newman AB, Sleep AHEAD Research Group. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep. 2012 Sep 1; 35(9):1293-8.
  78. Brautbar A, Pompeii LA, Dehghan A, Ngwa JS, Nambi V, Virani SS, Rivadeneira F, Uitterlinden AG, Hofman A, Witteman JC, Pencina MJ, Folsom AR, Cupples LA, Ballantyne CM, Boerwinkle E. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug 1; 223(2):421-6.
  79. Virani SS, Woodard LD, Wang D, Landrum CR, Chitwood SS, Urech TH, Pietz K, Hertz B, Ballantyne CM, Petersen LA. Correlates of multiple lipid panels in patients with coronary heart disease who have achieved LDL cholesterol treatment goals. Poster session presented at: VA HSR&D National Meeting; 2012 Jul 18; Washington, DC.
  80. Dugan J, Virani SS, Ho V. Medicare eligibility and physician utilization among adults with coronary heart disease and stroke. Medical care. 2012 Jun 1; 50(6):547-53.
  81. Crowley MJ, Powers BJ, Myers ER, McBroom AJ, Sanders GD. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization. American heart journal. 2012 May 1; 163(5):777-782.e8.
  82. Nambi V, Boerwinkle E, Lawson K, Brautbar A, Chambless L, Franeschini N, North KE, Virani SS, Folsom AR, Ballantyne CM. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May 1; 222(1):135-7.
  83. Gaubatz JW, Sun W, Jiang J, Buchanan A, Couper D, Virani S, Boerwinkle E, Ballantyne CM, Hoogeveen RC. Small dense LDL (sd-LDL) is associated with risk for coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference; 2012 Apr 18; Chicago, IL.
  84. Trivedi RB, Gerrity M, Doak M, Lucas L, Spertus J, Rumsfeld J, Sun H, McDonell M, Fihn SD. Depressive symptoms and angina burden in ischemic heart disease (IHD) patients: The Collaborative Cardiac Care Project. Presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2012 Apr 14; New Orleans, LA.
  85. Polonsky T, Chambless L, Mao L, Greenland P, Virani S, Astor B, Fox E, Hoogeveen R, Mosely T, Ni H, Ballantyne CM, Nambi V. High sensitivity C-reactive protein and family history in the prediction of risk for coronary heart disease: The atherosclerosis risk in communities (ARIC) study. Poster session presented at: American Heart Association Epidemiology and Prevention, Nutrition, Physical Activity, and Metabolism Scientific Sessions; 2012 Mar 14; San Diego, CA.
  86. Gopaldas RR, Chu D, Bakaeen FG. Acquired heart disease: Coronary insufficiency. In: Townsend, Jr. CM, Beauchamp RD, Evers BM, Mattox KL, editors. Sabiston Textbook of Surgery. 19 ed. Philadelphia, PA: Saunders; 2012. Chapter 60. 1650-1678 p.
  87. Welles CC, Ku IA, Kwan DM, Whooley MA, Schiller NB, Turakhia MP. Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study. Journal of the American College of Cardiology. 2012 Feb 14; 59(7):673-80.
  88. Galper BZ, Moran A, Coxson PG, Pletcher MJ, Heidenreich P, Lazar LD, Rodondi N, Wang YC, Goldman L. Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation. 2012 Jan 17; 125(2):260-70.
  89. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3; 125(1):188-97.
  90. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3; 125(1):e2-e220.
  91. Lin EH, Von Korff M, Ciechanowski P, Peterson D, Ludman EJ, Rutter CM, Oliver M, Young BA, Gensichen J, McGregor M, McCulloch DK, Wagner EH, Katon WJ. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Annals of Family Medicine. 2012 Jan 1; 10(1):6-14.
  92. Yang EY, Chambless L, Sharrett AR, Virani SS, Liu X, Tang Z, Boerwinkle E, Ballantyne CM, Nambi V. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan 1; 43(1):103-8.
  93. Hanks D. Management eBrief-e: Treatment of Anemia in Patients with Heart Disease. 2011 Nov 9; 4(46).
  94. Kansagara D, Dyer E, Englander H, Freeman M, Kagen D. Treatment of Anemia in Patients with Heart Disease: A Systematic Review. 1 ed. Washington (DC): Department of Veterans Affairs (US); 2011. 1-82 p.
  95. Fihn SD, Bucher JB, McDonell M, Diehr P, Rumsfeld JS, Doak M, Dougherty C, Gerrity M, Heidenreich P, Larsen G, Lee PI, Lucas L, McBryde C, Nelson K, Plomondon ME, Stadius M, Bryson C. Collaborative care intervention for stable ischemic heart disease. Archives of internal medicine. 2011 Sep 12; 171(16):1471-9.
  96. Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS(2) score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study. American heart journal. 2011 Sep 1; 162(3):555-61.
  97. Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Rodriguez Barradas MC, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Justice AC, Veterans Aging Cohort Study. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circulation. Cardiovascular quality and outcomes. 2011 Jul 1; 4(4):425-32.
  98. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 5; 123(13):1367-76.
  99. Welles CC, Na B, Whooley M, Turakhia M. CHADS2 Score Predicts Ischemic Stroke in the Absence of Atrial Fibrillation Among Patients With Coronary Heart Disease: Data from the Heart and Soul Study. Poster session presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 5; New Orleans, LA.
  100. Nambi V, Saunders J, Chambless L, de Lemos JA, Liu X, Virani SS, Boerwinkle E, Hoogeveen RC, Astor BC, Mosley TH, Folsom AR, Coresh J, Ballantyne CM. High sensitivity troponin is associated with mortality, coronary heart disease, and heart failure in individuals with prevalent cardiovascular disease in the atherosclerosis risk in communities (ARIC Study). Paper presented at: American College of Cardiology Annual Scientific Session; 2011 Apr 2; New Orleans, LA.
  101. Powers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication. American heart journal. 2011 Apr 1; 161(4):673-80.
  102. Powers BJ, Danus SM, Grubber J, Olsen MK, Oddone EZ, Bosworth HB. The Effectiveness of Personalized Coronary Heart Disease and Stroke Risk Communication. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 17; National Harbor, MD.
  103. Owens DK. Comparative Effectiveness of Treatments for Stable Ischemic Heart Disease: Evaluating Effects in Subgroups and Accounting for Rapid Technological Advances. Presented at: National Institutes of Health / Agency for Healthcare Research and Quality Conference on Methodological Challenges in Comparative Effectiveness Research; 2010 Dec 2; Bethesda, MD.
  104. Bosworth HB, Powers BJ, Oddone EZ. Patient self-management support: novel strategies in hypertension and heart disease. Cardiology Clinics. 2010 Nov 1; 28(4):655-63.
  105. Sanders GD, Powers B, Crowley M, Myers E, McBroom A, Musty M, Gray R. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 18. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Nov 1. 6 p. Report No.: 10-EHC006-EF.
  106. Duffy SA. Michigan Operating Engineers: Heart Disease and Cancer in the Making. Paper presented at: International Occupational Hygiene Association International Scientific Conference; 2010 Sep 28; Rome, Italy.
  107. Sanders GD, Powers BJ, Powers BJ, Crowley M. Future Research Needs for Angiotensin Converting Enzyme (ACE) Inhibitors or Angiotensin II Recepton Blockers (ARBs) added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease. Rockville, MD: Agency for Healthcare Research and Quality; 2010 Sep 1. 1-10 p. Report No.: 18.
  108. Shen C, Findley P, Banerjea R, Sambamoorthi U. Depressive disorders among cohorts of women veterans with diabetes, heart disease, and hypertension. Journal of women's health (2002). 2010 Aug 1; 19(8):1475-86.
  109. Popescu I, Nallamothu BK, Vaughan-Sarrazin MS, Cram P. Racial differences in admissions to high-quality hospitals for coronary heart disease. Archives of internal medicine. 2010 Jul 26; 170(14):1209-15.
  110. Duffy SA. Michigan Operating Engineers: Heart Disease and Cancer in the Making. Poster session presented at: Albert J. Silverman Research Annual Conference; 2010 May 12; Ann Arbor, MI.
  111. Lowery CM, Bargas RL, Stees CS, Schuller JL, Belardi DF, Aleong RG, Khoo MC, Varosy PD, Sauer WH. Induction of Ventricular Fibrillation is not necessary for Successful Ablation in Patients with Structural Heart Disease and Severe Heart Failure. Paper presented at: Heart Rhythm Society Annual Scientific Sessions; 2010 May 1; Denver, CO.
  112. Xian H, Scherrer JF, Franz CE, McCaffery J, Stein PK, Lyons MJ, Jacobsen K, Eisen SA, Kremen WS. Genetic vulnerability and phenotypic expression of depression and risk for ischemic heart disease in the Vietnam era twin study of aging. Psychosomatic medicine. 2010 May 1; 72(4):370-5.
  113. Duffy SA. Michigan Operating Engineers: Heart Disease and Cancer in the Making. Poster session presented at: University of Michigan School of Nursing Dean's Lecture and Research Day Conference; 2010 Apr 6; Ann Arbor, MI.
  114. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010 Feb 23; 121(7):948-54.
  115. Rose AJ, Ozonoff A, Henault LE, Hylek EM. Anticoagulation for valvular heart disease in community-based practice. Thrombosis and Haemostasis. 2010 Feb 1; 103(2):329-37.
  116. Axon RN, Zhao Y, Egede LE. Association of depressive symptoms with all-cause and ischemic heart disease mortality in adults with self-reported hypertension. American journal of hypertension. 2010 Jan 1; 23(1):30-7.
  117. Deo R, Shlipak MG, Ix JH, Ali S, Schiller NB, Whooley MA. Association of cystatin C with ischemia in patients with coronary heart disease. Clinical Cardiology. 2009 Nov 1; 32(11):E18-22.
  118. Roumie CL, Choma NN, Kaltenbach L, Mitchel EF, Arbogast PG, Griffin MR. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiology and drug safety. 2009 Nov 1; 18(11):1053-63.
  119. McSweeney JC, Pettey CM, Fischer EP, Spellman A. Going the distance: overcoming challenges in recruitment and retention of Black and White women in multisite, longitudinal study of predictors of coronary heart disease. Research in gerontological nursing. 2009 Oct 27; 2(4):256-64.
  120. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Annals of internal medicine. 2009 Oct 6; 151(7):483-95.
  121. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, Humphrey LL. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Annals of internal medicine. 2009 Oct 6; 151(7):496-507.
  122. U. S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2009 Oct 6; 151(7):474-82.
  123. Turakhia MP, McManus DD, Whooley MA, Schiller NB. Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study. European heart journal. 2009 Oct 1; 30(20):2478-84.
  124. Bossi KE. HSR&D Pub eBriefs-d, Jul 09-Hypertension, SCI, Diabetes, Duty Hour Reform, Heart Disease. 2009 Jul 16; 1(4).
  125. Tsui JI, Whooley MA, Monto A, Seal K, Tien PC, Shlipak M. Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. Journal of cardiac failure. 2009 Jun 1; 15(5):451-6.
  126. Fihn SD. Effect of a Collaborative Care Intervention on Patients with ischemic Heart Disease. Presented at: Society of General Internal Medicine Annual Meeting; 2009 May 13; Miami, FL.
  127. Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart. 2009 Mar 1; 95(3):252-8.
  128. Lipscomb ER, Finch EA, Brizendine E, Saha CK, Hays LM, Ackermann RT. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study. Diabetes Care. 2009 Mar 1; 32(3):394-6.
  129. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. Journal of general internal medicine. 2008 Dec 1; 23(12):2079-86.
  130. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, Schiller NB, Browner WS. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA : the journal of the American Medical Association. 2008 Nov 26; 300(20):2379-88.
  131. Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clinic proceedings. Mayo Clinic. 2008 Nov 1; 83(11):1203-12.
  132. Chang VW. Affect and heart disease. [Editorial]. BMJ (Clinical research ed.). 2008 Jun 30; 337:a177.
  133. Deo R, Lin F, Vittinghoff E, Tseng ZH, Hulley SB, Shlipak MG. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension. 2008 Jun 1; 51(6):1578-82.
  134. Sales A, Helfrich C, Ho PM, Hedeen A, Plomondon ME, Li YF, Connors A, Rumsfeld JS. Implementing electronic clinical reminders for lipid management in patients with ischemic heart disease in the veterans health administration: QUERI Series. Implementation science : IS. 2008 May 29; 3:28.
  135. Wyrwich KW, Metz SM, Kroenke K, Tierney WM, Babu AN, Wolinsky FD. Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. Health services research. 2007 Dec 1; 42(6 Pt 1):2257-74; discussion 2294-323.
  136. Rumsfeld JS. Women and Heart Disease: Insights from Registry Data. Paper presented at: American Heart Association Annual Scientific Sessions; 2007 Nov 1; Orlando, FL.
  137. Hravnak M, Whittle J, Kelley ME, Sereika S, Good CB, Ibrahim SA, Conigliaro J. Symptom expression in coronary heart disease and revascularization recommendations for black and white patients. American journal of public health. 2007 Sep 1; 97(9):1701-8.
  138. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007 May 15; 115(19):2533-9.
  139. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007 Feb 6; 115(5):e69-171.
  140. Vargas RB, Mangione CM, Asch S, Keesey J, Rosen M, Schonlau M, Keeler EB. Can a chronic care model collaborative reduce heart disease risk in patients with diabetes? Journal of general internal medicine. 2007 Feb 1; 22(2):215-22.
  141. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007 Jan 16; 115(2):173-9.
  142. Goff DC, Brass L, Braun LT, Croft JB, Flesch JD, Fowkes FG, Hong Y, Howard V, Huston S, Jencks SF, Luepker R, Manolio T, O'Donnell C, Robertson RM, Rosamond W, Rumsfeld J, Sidney S, Zheng ZJ, American Heart Association Council on Epidemiology and Prevention, American Heart Association Council on Stroke, American Heart Association Council on Cardiovascular Nursing, American Heart Association Working Group on Quality of Care and Outcomes Research, American Heart Association Working Group on Atherosclerotic Peripheral Vascular Disease. Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease. Circulation. 2007 Jan 2; 115(1):127-55.
  143. Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC cardiovascular disorders. 2006 Dec 15; 6:48.
  144. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology. 2006 May 1; 43(5):1145-51.
  145. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 Feb 14; 113(6):e85-151.
  146. Ho PM, Prochazka AV, Magid DJ, Sales AE, Grunwald GK, Hammermeister KE, Rumsfeld JS. The association between processes, structures and outcomes of secondary prevention care among VA ischemic heart disease patients. BMC cardiovascular disorders. 2006 Feb 9; 6:6.
  147. Shah MG, Cho S, Atwood JE, Heidenreich PA. Peripheral edema due to heart disease: diagnosis and outcome. Clinical Cardiology. 2006 Jan 1; 29(1):31-5.
  148. Mehta SB, Wu WC. Management of coronary heart disease: stable angina, acute coronary syndrome, myocardial infarction. Primary Care. 2005 Dec 1; 32(4):1057-81.
  149. Massie BM. Heart Disease. In: Tierney LM, McPhee S, editors. Current Medical Diagnosis and Treatment. 45th ed. Norwalk, CT: Lange Medical Books; 2005.
  150. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). American Journal of Audiology. 2005 Oct 15; 96(8):1076-81.
  151. Gehi A, Ix J, Shlipak M, Pipkin SS, Whooley MA. Relation of anemia to low heart rate variability in patients with coronary heart disease (from the Heart and Soul study). American Journal of Audiology. 2005 Jun 15; 95(12):1474-7.
  152. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005 Jun 1; 28(6):1339-45.
  153. Gehi A, Mangano D, Pipkin S, Browner WS, Whooley MA. Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Archives of general psychiatry. 2005 Jun 1; 62(6):661-6.
  154. Elkins JS, Knopman DS, Yaffe K, Johnston SC. Cognitive function predicts first-time stroke and heart disease. Neurology. 2005 May 24; 64(10):1750-5.
  155. Spies C, Otte C, Kanaya A, Pipkin SS, Schiller NB, Whooley MA. Association of metabolic syndrome with exercise capacity and heart rate recovery in patients with coronary heart disease in the heart and soul study. American Journal of Audiology. 2005 May 15; 95(10):1175-9.
  156. Chan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study. Journal of the American College of Cardiology. 2005 May 3; 45(9):1474-81.
  157. Fan VS, Reiber GE, Diehr P, Burman M, McDonell MB, Fihn SD. Functional status and patient satisfaction: a comparison of ischemic heart disease, obstructive lung disease, and diabetes mellitus. Journal of general internal medicine. 2005 May 1; 20(5):452-9.
  158. Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health services research. 2005 Apr 1; 40(2):577-91.
  159. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, Harrison DG, Quyyumi AA, Vaccarino V. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis. 2005 Jan 1; 178(1):115-21.
  160. Woodard LD, Kressin NR, Petersen LA. Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system? American journal of public health. 2004 Dec 1; 94(12):2112-7.
  161. Chan P, Hayward RA. Predicting 1-Year Mortality in Patients Receiving Implantable Cardioverter-Defibrillators for Congestive Heart Failure, Ischemic Heart Disease, and Ventricular Arrhythmias. Paper presented at: American Heart Association Annual Scientific Sessions; 2004 Nov 1; New Orleans, LA.
  162. Kaur S, Cohen A, Dolor R, Coffman CJ, Bastian LA. The impact of environmental tobacco smoke on women's risk of dying from heart disease: a meta-analysis. Journal of women's health. 2004 Oct 1; 13(8):888-97.
  163. Chan P, Hayward RA. Mortality Reduction by Implantable Cardioverter-Defibrillators in VA Patients with Ischemic Heart Disease, Congestive Heart Failure, and a History of Ventricular Arrhythmias. Paper presented at: Heart Failure Society of America Annual Scientific Meeting; 2004 Sep 13; Toronto, Canada.
  164. Pineros SL, Sales AE, Li Y, Sharp ND. Improving care to patients with ischemic heart disease: experiences in a single network of the Veterans Health Administration. Worldviews on evidence-based nursing / Sigma Theta Tau International, Honor Society of Nursing. 2004 Sep 1; 1(Suppl 1):S33-S40.
  165. Otte C, Marmar CR, Pipkin SS, Moos R, Browner WS, Whooley MA. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biological psychiatry. 2004 Aug 15; 56(4):241-7.
  166. Egede LE, Nietert P, Zheng D. Depression is Associated with Increased Risk of Death from Coronary Heart Disease in Individuals with Diabetes. Paper presented at: Australian Diabetes Society Annual Meeting; 2004 Aug 1; Sydney, Australia.
  167. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M, Larsen G, McCall A, Pineros S, Sales A. Effectiveness of statin therapy in adults with coronary heart disease. Archives of internal medicine. 2004 Jul 12; 164(13):1427-36.
  168. Douglas M. Women and heart disease: A cross cultural study of symptom management. Paper presented at: Transcultural Nursing Society Annual Conference; 2004 Jun 15; Alicante, Spain.
  169. Egede LE, Nietert P, Zheng D. Depression and Coronary Heart Disease Mortality in Individuals with Diabetes. Poster session presented at: American Diabetes Association Annual Scientific Session; 2004 Jun 4; Orlando, FL.
  170. Fincher C, Williams JE, MacLean V, Allison JJ, Kiefe CI, Canto J. Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethnicity & disease. 2004 Jun 1; 14(3):360-71.
  171. Ohldin A, Young B, Derleth A, McDonell M, Diehr P, Kiefe C, Fihn S. Ethnic differences in satisfaction and quality of life in veterans with ischemic heart disease. Journal of the National Medical Association. 2004 Jun 1; 96(6):799-808.
  172. Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. American heart journal. 2004 Apr 1; 147(4):615-22.
  173. Janket SJ, Qvarnström M, Meurman JH, Baird AE, Nuutinen P, Jones JA. Asymptotic dental score and prevalent coronary heart disease. Circulation. 2004 Mar 9; 109(9):1095-100.
  174. Pignone M, Sheridan SL, Lee YZ, Kuo J, Phillips C, Mulrow C, Zeiger R. Heart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary prevention. Preventive Cardiology. 2004 Jan 1; 7(1):26-33.
  175. Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD. Creatinine levels and cardiovascular events in women with heart disease: do small changes matter? American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Jan 1; 43(1):37-44.
  176. Tierney WM, Overhage JM, Murray MD, Harris LE, Zhou XH, Eckert GJ, Smith FE, Nienaber N, McDonald CJ, Wolinsky FD. Effects of computerized guidelines for managing heart disease in primary care. Journal of general internal medicine. 2003 Dec 1; 18(12):967-76.
  177. Rubins HB, Nelson DB, Noorbaloochi S, Nugent S. Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System. American Journal of Audiology. 2003 Nov 15; 92(10):1177-82.
  178. Kopjar B, Sales AE, Piñeros SL, Sun H, Li YF, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. The American journal of cardiology. 2003 Nov 1; 92(9):1106-8.
  179. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation. 2003 Sep 2; 108(9):1089-94.
  180. Varosy PD, Shlipak MG, Vittinghoff E, Black DM, Herrington D, Hulley SB, Browner WS. Fracture and the risk of coronary events in women with heart disease. The American journal of medicine. 2003 Aug 15; 115(3):196-202.
  181. Kopjar B, Sales AE, Piñeros SL, Sun H, Li YF, Hedeen AN. Comparison of characteristics of patients with coronary heart disease receiving lipid-lowering therapy versus those not receiving such therapy. The American journal of cardiology. 2003 Jun 1; 91(11):1352-4.
  182. Miller R. Underuse of cardioprotective medications in ischemic heart disease patients prior to acute myocardial infarction. Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 May 1; Vancouver, Canada.
  183. Ho PM, Maynard C, Starks H, Sun H, Sloan K, Sales A. Outcomes in patients with coronary heart disease who do not undergo lipid testing. The American journal of cardiology. 2003 Apr 15; 91(8):986-8, A7.
  184. Khan MA, Hlatky MA, Liu MW, Lin F, Rogers WJ, Shlipak MG. Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty. American Journal of Audiology. 2003 Apr 15; 91(8):989-91, A7.
  185. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. The American journal of clinical nutrition. 2003 Feb 1; 77(2):319-25.
  186. Wilt TJ, Rubins HB, MacDonald R, Rutks I, Nelson D, Pineros S, Larsen G. Effectiveness of statins in adults with coronary heart disease: A systematic review and meta-analysis of evidence from randomized controlled trials. 2003 Feb 1.
  187. Vittinghoff E, Shlipak MG, Varosy PD, Furberg CD, Ireland CC, Khan SS, Blumenthal R, Barrett-Connor E, Hulley S. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Annals of internal medicine. 2003 Jan 21; 138(2):81-9.
  188. Woodard LD, Kressin NR, Petersen LA. Comparison of medication use in coronary heart disease patients with and without diabetes. Journal of general internal medicine. 2003 Jan 1; 18(Suppl 1):299-299.
  189. Woodard LD, Kressin NR, Petersen LA. Examining disparities in cholesterol monitoring and treatment among veterans with coronary heart disease. Paper presented at: Kelsey Research Foundation Health Services and Outcomes Research Annual Conference; 2002 Nov 1; Houston, TX.
  190. Biswas MS, Calhoun PS, Bosworth HB, Bastian LA. Are women worrying about heart disease? Women's health issues : official publication of the Jacobs Institute of Women's Health. 2002 Jul 1; 12(4):204-11.
  191. Biswas MS, Bastian LA. Risk factors for heart disease among women: Communicating probabilities of disease. Journal of clinical outcomes management : JCOM. 2002 Jun 1; 9(6):333-340.
  192. Bibbins-Domingo K, Ansari M, Schiller N, Whooley M. B-type natriuretic peptide and exercise-induced ischemia among patients with stable coronary heart disease: The Heart and Soul Study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
  193. Frayne SM, Crawford SL, McGraw SA, Smith KW, McKinlay JB. Help-seeking behaviors of blacks and whites dying from coronary heart disease. Ethnicity And Health. 2002 May 1; 7(2):77-86.
  194. Ruo B, Whooley M. Predictors of quality of life in patients with coronary heart disease: The Heart and Soul Study. Paper presented at: Society of General Internal Medicine Annual Meeting; 2002 May 1; Atlanta, GA.
  195. Natarajan S, Liao Y, Sinha D, Cao G, Lipsitz SR, McGee DL. Longstanding Diabetes Is Associated with Greater Risk for Coronary Heart Disease Mortality in Women than Prevalent Coronary Heart Disease. Paper presented at: American Heart Association Cardiovascular Disease Epidemiology and Prevention Annual Conference; 2002 Apr 4; Honolulu, HI.
  196. Ho P, Starks H, Sun H, Sloan K, Sales A, Maynard C. Adverse outcomes in ischemic heart disease patients who do not undergo a lipid measurement. Paper presented at: VA HSR&D National Meeting; 2002 Feb 14; Washington, DC.
  197. Massie BM. Heart disease. In: Tierney LM, McPhee S, editors. Current Medical Diagnosis and Treatment. Norwalk, CT: Lange Medical Books; 2001.
  198. Massie BM. Heart disease and the surgical patient. In: Way LE, editor. Current Surgical Diagnosis and Therapy. Norwalk, CT: Lange Medical Books; 2001.
  199. Sloan K, Sales A, Pineros S, Rothendler J. Comparing process and outcomes measures in the evaluation of ischemic heart disease secondary prevention. Paper presented at: AcademyHealth Annual Research Meeting; 2001 Jun 12; Atlanta, GA.
  200. Biswas MS, Calhoun PS, Bosworth HB, Bastian LA. Are women veterans worrying about heart disease? Paper presented at: Society of General Internal Medicine Annual Meeting; 2001 May 1; San Diego, CA.
  201. Lemaitre R, Siscovick D, King I, Mozaffarian D, Kuller L, Tracy R. Plasma phospholipid n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and non-fatal myocardial infarction in older adults: the Cardiovascular Health Study. Paper presented at: American Heart Association Annual Scientific Sessions; 2001 Mar 15; San Antonio, TX.
  202. Mozaffarian D, Lemaitre R, Kuller L, Fried L, Siscovick D. Fatty fish consumption and ischemic heart disease mortality in older adults: the Cardiovascular Health Study. Paper presented at: American Heart Association Annual Scientific Sessions; 2001 Mar 15; San Antonio, TX.
  203. Wilt T, Mac Donald, Nelson D, Pineros S. LDL cholesterol goals for secondary prevention of coronary heart disease. A systematic review of the evidence. Department of Veterans Affairs Office of Research and Development; 2001 Mar 1.
  204. Sales A, Pineros S, Sloan K, Starks H. Lipid Measurement and Management among VA Patients with Ischemic Heart Disease. Paper presented at: VA HSR&D National Meeting; 2001 Feb 14; Washington, DC.
  205. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Gender-Specific Effect of Coronary Heart Disease and Diabetes Mellitis on Coronary Heart Disease Mortality. Presented at: Epidemiology Annual Congress; 2001 Jan 1; Toronto, Canada.
  206. Whitsel EA, Raghunathan TE, Pearce RM, Lin D, Rautaharju PM, Lemaitre R, Siscovick DS. RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease. European heart journal. 2001 Jan 1; 22(2):165-73.
  207. Whitsel E, Boyko E, Rautaharju P. QT interval prolongation and risk of primary cardiac arrest in diabetic patients without clinically recognized heart disease. Circulation. 2000 Sep 15; 101(6):25:716.
  208. Every NR, Fihn SD, Sales AE, Keane A, Ritchie JR. Quality Enhancement Research Initiative in ischemic heart disease: a quality initiative from the Department of Veterans Affairs. QUERI IHD Executive Committee. Medical care. 2000 Jun 1; 38(6 Suppl 1):I49-59.
  209. Sales A. Secondary prevention for Ischemic Heart Disease: Guideline concordance. Paper presented at: VA HSR&D National Meeting; 2000 Mar 22; Washington, DC.
  210. Brown AI, Garber AM. A concise review of the cost-effectiveness of coronary heart disease prevention. The Medical Clinics of North America. 2000 Jan 1; 84(1):279-97, xi.
  211. Whitsel E, Pearce R, Raghunathan TE, Lin D, Rautaharju P, Weinmann S, Anderson G, Arbogast P, Siscovick D. Electrocardiographic indicators of autonomic dysfunction and risk of primary cardiac arrest among patients without clinically recognized heart disease. [Abstract]. Circulation. 1999 Sep 15; 99(8):58-58.
  212. Brown A, Garber A. Cost effectiveness of coronary heart disease prevention strategies in adults. In: Mallarkey G, editor. Aspects of Hypertension Management. Auckland, New Zealand: Adis International Limited; 1999. 85-106 p.
  213. Brown AD, Garber AM. Cost effectiveness of coronary heart disease prevention strategies in adults. Pharmacoeconomics. 1998 Jul 1; 14(1):27-48.
  214. Fujimoto WY, Boyko EJ, Chen KW, Leonetti DL, Newell ML, Wahl PW. Visceral adiposity, blood pressure, and glucose are independent risk factors for coronary heart disease. Paper presented at: International Diabetes Federation World Triennial Congress; 1997 Jul 1; Helsinki, Finland.
  215. Fujimoto WY, Boyko EJ, Chen KW, Leonetti DL, Newell ML, Wahl PW. Visceral adiposity, glycemia, and high blood pressure increase the risk of coronary heart disease. Paper presented at: American Diabetes Association Annual Scientific Session; 1997 Jun 1; Boston, MA.
  216. Liao D, Cai J, Rosamond WD, Barnes RW, Hutchinson RG, Whitsel EA, Rautaharju P, Heiss G. Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. American journal of epidemiology. 1997 Apr 15; 145(8):696-706.

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.